Phase 2, open label, multicenter study of pacritinib in relapsed/refractory T-cell lymphoproliferative neoplasms 

Status: Open to Accrual

Learn more: 

• https://clinicaltrials.gov/study/NCT04858256

Study Contact: studies@hoosiercancer.org; (317) 921-2050.